Histogen Inc. buy krebskrebs
Start price
19.10.20
/
50%
€38.00
Target price
04.11.21
€40.00
Performance (%)
-65.26%
End price
05.11.21
€13.20
Summary
This prediction ended on 05.11.21 with a price of €13.20. The BUY prediction by krebskrebs for Histogen Inc. performed very badly with a performance of -65.26%. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Histogen Inc. | - | - | - | - |
| iShares Core DAX® | -4,93 % | -11,98 % | -3,49 % | 44,54 % |
| iShares Nasdaq 100 | -2,63 % | -2,22 % | 13,78 % | 80,99 % |
| iShares Nikkei 225® | -4,73 % | -10,90 % | 19,71 % | 45,26 % |
| iShares S&P 500 | -2,54 % | -3,54 % | 8,88 % | 61,12 % |
Comments by krebskrebs for this prediction
In the thread Histogen Inc. diskutieren
In the thread Trading Histogen Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten